Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.40 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | ACACB | O00763 | 1/20 | 0.35 |
| ▸ | ACACA | Q13085 | 1/20 | 0.35 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.35 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.35 |
| ▸ | MMP2 | P08253 | 2/20 | 0.35 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.35 |
| ▸ | RAD52 | P43351 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 3/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16830092 | 1.00 | FFAR4 (0.42) | FFAR4FFAR1GPR84FAAHNFKB1 | |
| SCHEMBL8839013 | 1.00 | FFAR4 (0.42) | FFAR4FFAR1GPR84FAAHNFKB1 | |
| SCHEMBL29259417 | 1.00 | FFAR4 (0.42) | FFAR4FFAR1GPR84FAAHNFKB1 | |
| SCHEMBL16826320 | 1.00 | FFAR4 (0.42) | FFAR4FFAR1GPR84FAAHNFKB1 | |
| SCHEMBL8839011 | 1.00 | FFAR4 (0.42) | FFAR4FFAR1GPR84FAAHNFKB1 | |
| SCHEMBL16829838 | 1.00 | FFAR4 (0.42) | FFAR4FFAR1GPR84FAAHNFKB1 | |
| SCHEMBL16829715 | 0.93 | FFAR4 (0.42) | FFAR4FFAR1GPR84FAAHNFKB1 | |
| SCHEMBL26697565 | 0.93 | FFAR4 (0.42) | FFAR4FFAR1GPR84FAAHNFKB1 | |
| SCHEMBL16829966 | 0.93 | FFAR4 (0.42) | FFAR4FFAR1GPR84FAAHNFKB1 | |
| SCHEMBL26697559 | 0.93 | FFAR4 (0.42) | FFAR4FFAR1GPR84FAAHNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114945557-B | Fatty acid derivatives labeled with positron radionuclides | 安斯泰来制药株式会社 | 2024-06-04 | — | — | CN | disclosed |
| CN-114945557-A | Fatty acid derivatives labelled with positron-emitting radionuclides | 安斯泰来制药株式会社 | 2022-08-26 | — | — | CN | disclosed |
| EP-4019506-A1 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | Novartis AG (CH) | 2022-06-29 | — | — | EP | disclosed |
| EP-3083579-B1 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | NOVARTIS AG (CH) | 2022-01-26 | — | — | EP | disclosed |
| US-11013696-B2 | Lipids and lipid compositions for the delivery of active agents | NOVARTIS AG (CH) | 2021-05-25 | — | — | US | disclosed |
| US-10426737-B2 | Lipids and lipid compositions for the delivery of active agents | NOVARTIS AG (CH) | 2019-10-01 | — | — | US | disclosed |
| US-20160317458-A1 | Lipids and Lipid Compositions for the Delivery of Active Agents | NOVARTIS AG (CH) | 2016-11-03 | — | — | US | disclosed |
| EP-3083579-A1 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | Novartis AG (CH) | 2016-10-26 | — | — | EP | disclosed |
| WO-2015095346-A1 | LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS | NOVARTIS AG (CH) | 2015-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160317458-A1 | Lipids and Lipid Compositions for the Delivery of Active Agents | SGMS1, PHOSPHO1, LIPA | FFAR4 508/4885FFAR1 270/4885GPR84 2335/4885 |
| US-10426737-B2 | Lipids and lipid compositions for the delivery of active agents | SGMS1, PHOSPHO1, LIPA | FFAR4 508/4885FFAR1 270/4885GPR84 2335/4885 |
| US-11013696-B2 | Lipids and lipid compositions for the delivery of active agents | PHOSPHO1, SGMS1, LIPA | FFAR4 563/4885FFAR1 299/4885GPR84 2232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.